Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806570 · ClinicalTrials.gov registry record · NA
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study
A NA study, sponsored by Ancora Heart.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02806570 is a NA study that has completed, run by Ancora Heart. The registered enrollment target is 35 participants.
The verdict
NCT02806570, a NA study, has completed, sponsored by Ancora Heart.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy
Interventions
- DEVICE Mitral valve repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-08 |
| Est. Completion | 2024-08-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02806570
The ClinicalTrials.gov registry entry for NCT02806570 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ancora Heart, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mitral valve repair is the first listed.
NCT02806570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02806570 about?
NCT02806570 is a clinical study titled "The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study". This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy
What is the current status of trial NCT02806570?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-08. Estimated completion is 2024-08-22.
What interventions are being tested in trial NCT02806570?
The interventions under investigation include: Mitral valve repair (DEVICE).
Who is sponsoring clinical trial NCT02806570?
This trial is sponsored by Ancora Heart, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.